ArticleBMC nephrology2019

Treatment with intravenous immunoglobulins and methylprednisolone may significantly decrease loss of renal function in chronic-active antibody-mediated rejection.

Kasia A Sablik et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.